» Articles » PMID: 36833234

Association of Gene Rs6127099 (A > T) Polymorphism with Lower Risk to COVID-19 Infection in Kazakhstan

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2023 Feb 25
PMID 36833234
Authors
Affiliations
Soon will be listed here.
Abstract

In December 2019, SARS-CoV-2 was identified in Wuhan, China. Infection by SARS-CoV-2 causes coronavirus disease 2019 (COVID-19), which is characterized by fever, cough, dyspnea, anosmia, and myalgia in many cases. There are discussions about the association of vitamin D levels with COVID-19 severity. However, views are conflicting. The aim of the study was to examine associations of vitamin D metabolism pathway gene polymorphisms with symptomless COVID-19 susceptibility in Kazakhstan. The case-control study examined the association between asymptomatic COVID-19 and vitamin D metabolism pathway gene polymorphisms in 185 participants, who previously reported not having COVID-19, were PCR negative at the moment of data collection, and were not vaccinated. A dominant mutation in rs6127099 () was found to be protective of asymptomatic COVID-19. Additionally, the G allele of rs731236 TaqI (), dominant mutation in rs10877012 (), recessive rs1544410 BsmI (), and rs7041 () are worth consideration since they were statistically significant in bivariate analysis, although their independent effect was not found in the adjusted multivariate logistic regression model.

Citing Articles

Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy.

Gomaa A, Abdel-Wadood Y, Thabet R, Gomaa G Inflammopharmacology. 2023; 32(1):249-271.

PMID: 37957515 PMC: 10907442. DOI: 10.1007/s10787-023-01383-x.

References
1.
Apaydin T, Polat H, Yazan C, Ilgin C, Elbasan O, Dashdamirova S . Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID-19. Clin Endocrinol (Oxf). 2021; 96(6):819-830. DOI: 10.1111/cen.14664. View

2.
Deodatus J, Kooistra S, Kurstjens S, Mossink J, van Dijk J, Groeneveld P . Lower plasma calcium associated with COVID-19, but not with disease severity: a two-centre retrospective cohort study. Infect Dis (Lond). 2021; 54(2):90-98. PMC: 8500306. DOI: 10.1080/23744235.2021.1981549. View

3.
Fishchuk L, Rossokha Z, Pokhylko V, Cherniavska Y, Tsvirenko S, Kovtun S . Modifying effects of , and genes on the development risk and the course of COVID-19. Pilot study. Drug Metab Pers Ther. 2021; 37(2):133-139. DOI: 10.1515/dmpt-2021-0127. View

4.
Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S . A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2020; 54(1):12-16. PMC: 7227597. DOI: 10.1016/j.jmii.2020.05.001. View

5.
Jain A, Chaurasia R, Sengar N, Singh M, Mahor S, Narain S . Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep. 2020; 10(1):20191. PMC: 7677378. DOI: 10.1038/s41598-020-77093-z. View